Status:
RECRUITING
Nurse Intervention Trial
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Haukeland University Hospital
Oslo University Hospital
Conditions:
Migraine
Chronic Tension-Type Headache
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. ...
Detailed Description
Potential patients suitable for this study must have undergone a regular consultation with a neurologist before. This consultation includes neurological and somatic examinations, diagnosis of the type...
Eligibility Criteria
Inclusion
- One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua
- Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness.
Exclusion
- Uncertain headache diagnosis.
- Need further investigation after the initial consultation.
- Lack of understanding of information provided in Norwegian, both verbally and in writing.
- Inability to keep a digital headache diary.
- Need treatment of other comorbid conditions requiring follow-up in specialized healthcare.
- Treatment with Onabotulinumtoxin A or Calcitonin-gene-related Peptide (CGRP) inhibitors given with three months intervals
Key Trial Info
Start Date :
April 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06200480
Start Date
April 21 2023
End Date
December 31 2027
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Olavs Hospital HF
Trondheim, Norway, 7489